We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Safety and Immunogenicity of EXG-5003

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04863131
Recruitment Status : Completed
First Posted : April 28, 2021
Last Update Posted : January 26, 2023
Elixirgen Therapeutics, Inc.
Information provided by (Responsible Party):
Yohei Doi, Fujita Health University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 31, 2022
Actual Study Completion Date : January 24, 2023